163 related articles for article (PubMed ID: 37562987)
21. [Fertility preservation techniques in women of reproductive age ].
Vulliemoz N ; Gaitzsch H ; Primi M-P ; Wunder D ; Perey L ; Streuli I
Rev Med Suisse; 2014 Oct; 10(447):1961-2, 1964-6, 1968. PubMed ID: 25518205
[TBL] [Abstract][Full Text] [Related]
22. Long term pregnancy outcomes of women with cancer following fertility preservation: A systematic review and meta-analysis.
Xu Z; Ibrahim S; Burdett S; Rydzewska L; Al Wattar BH; Davies MC
Eur J Obstet Gynecol Reprod Biol; 2023 Feb; 281():41-48. PubMed ID: 36535069
[TBL] [Abstract][Full Text] [Related]
23. Nationwide survey of fertility preservation in patients with hematological malignancies in Japan.
Okamoto S; Fujii N; Yoshioka N; Harada M; Tanimoto M; Maeda Y; Suzuki N; Osuga Y
Int J Clin Oncol; 2021 Feb; 26(2):438-442. PubMed ID: 33068221
[TBL] [Abstract][Full Text] [Related]
24. [Fertility preservation in oncology].
Chaput L; Grémeau AS; Vorilhon S; Pons H; Chabrot C; Grèze V; Pouly JL; Brugnon F
Bull Cancer; 2018 Jan; 105(1):99-110. PubMed ID: 29221621
[TBL] [Abstract][Full Text] [Related]
25. Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single center.
Poirot C; Brugieres L; Yakouben K; Prades-Borio M; Marzouk F; de Lambert G; Pacquement H; Bernaudin F; Neven B; Paye-Jaouen A; Pondarre C; Dhedin N; Drouineaud V; Chalas C; Martelli H; Michon J; Minard V; Lezeau H; Doz F; Sarnacki S; Philippe-Chomette P; Dufour C; Laurence V; Baruchel A; Wolf JP; Boissel N; Valteau-Couanet D; Dalle JH
Acta Obstet Gynecol Scand; 2019 May; 98(5):630-637. PubMed ID: 30919447
[TBL] [Abstract][Full Text] [Related]
26. In vitro maturation is a viable option for urgent fertility preservation in young women with hematological conditions.
Sonigo C; Bajeux J; Boubaya M; Eustache F; Sifer C; Lévy V; Grynberg M; Sermondade N
Hematol Oncol; 2020 Oct; 38(4):560-564. PubMed ID: 32065670
[TBL] [Abstract][Full Text] [Related]
27. Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience.
Mayeur A; Puy V; Windal V; Hesters L; Gallot V; Benoit A; Grynberg M; Sonigo C; Frydman N
J Assist Reprod Genet; 2021 Jul; 38(7):1767-1775. PubMed ID: 33797007
[TBL] [Abstract][Full Text] [Related]
28. Response to ovarian stimulation in patients facing gonadotoxic therapy.
Johnson LN; Dillon KE; Sammel MD; Efymow BL; Mainigi MA; Dokras A; Gracia CR
Reprod Biomed Online; 2013 Apr; 26(4):337-44. PubMed ID: 23415997
[TBL] [Abstract][Full Text] [Related]
29. Concise review: fertility preservation: an update.
González C; Boada M; Devesa M; Veiga A
Stem Cells Transl Med; 2012 Sep; 1(9):668-72. PubMed ID: 23197873
[TBL] [Abstract][Full Text] [Related]
30. Vitrification of human oocytes.
Coello A; Pellicer A; Cobo A
Minerva Ginecol; 2018 Aug; 70(4):415-423. PubMed ID: 29527869
[TBL] [Abstract][Full Text] [Related]
31. Fertility preservation for young adults, adolescents, and children with cancer.
Rodriguez-Wallberg KA; Anastacio A; Vonheim E; Deen S; Malmros J; Borgström B
Ups J Med Sci; 2020 May; 125(2):112-120. PubMed ID: 32356507
[TBL] [Abstract][Full Text] [Related]
32. The evolution of fertility preservation care models in a large pediatric cancer and blood disorders center.
Ludemann J; Pruett M; Klosky JL; Meacham L; Cherven B
Pediatr Blood Cancer; 2023 Jan; 70(1):e30052. PubMed ID: 36308423
[TBL] [Abstract][Full Text] [Related]
33. Advances in fertility preservation of female patients with hematological malignancies.
Salama M; Isachenko V; Isachenko E; Rahimi G; Mallmann P
Expert Rev Hematol; 2017 Nov; 10(11):951-960. PubMed ID: 28828900
[TBL] [Abstract][Full Text] [Related]
34. Fertility preservation in female patients with hematological disorders.
Wu D; Shen H
BMC Pregnancy Childbirth; 2022 Jan; 22(1):61. PubMed ID: 35065646
[TBL] [Abstract][Full Text] [Related]
35. Optimizing the process of fertility preservation in pediatric female cancer patients - a multidisciplinary program.
Ben-Aharon I; Abir R; Perl G; Stein J; Gilad G; Toledano H; Elitzur S; Avrahami G; Ben-Haroush A; Oron G; Freud E; Kravarusic D; Ben-Arush M; Herzel G; Yaniv I; Stemmer SM; Fisch B; Ash S
BMC Cancer; 2016 Aug; 16():620. PubMed ID: 27506811
[TBL] [Abstract][Full Text] [Related]
36. Fertility preservation in breast cancer with case-based examples for guidance.
Hampe ME; Rhoton-Vlasak AS
J Assist Reprod Genet; 2020 Mar; 37(3):717-729. PubMed ID: 32008180
[TBL] [Abstract][Full Text] [Related]
37. Effects of malignancies on fertility preservation outcomes and relevant cryobiological advances.
Liu D; Yan J; Qiao J
Sci China Life Sci; 2020 Feb; 63(2):217-227. PubMed ID: 31197760
[TBL] [Abstract][Full Text] [Related]
38. Cryopreservation of Oocytes Retrieved from Ovarian Tissue to Optimize Fertility Preservation in Prepubertal Girls and Women.
Brouillet S; Ferrieres-Hoa A; Fournier A; Martinez G; Bessonnat J; Gueniffey A; Gala A; Loup V; Hamamah S
J Vis Exp; 2020 Oct; (164):. PubMed ID: 33165323
[TBL] [Abstract][Full Text] [Related]
39. The Experience of Fertility Preservation in a Single Tertiary Center in Korea.
Choi YJ; Hong YH; Kim S; Kim SK; Lee JR; Suh CS
Front Endocrinol (Lausanne); 2022; 13():845051. PubMed ID: 35518927
[TBL] [Abstract][Full Text] [Related]
40. FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER.
Vuković P; Kasum M; Raguž J; Lonjak N; Bilić Knežević S; Orešković I; Beketić Orešković L; Čehić E
Acta Clin Croat; 2019 Mar; 58(1):147-156. PubMed ID: 31363337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
